Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Refined single-cell profiling captures a CCR5<sup>high</sup> CD4<sup>+</sup> cytotoxic T-cell precursor in multiple sclerosis.

EBioMedicine·2026
Same author

Induction of subtle blood-brain barrier dysfunction using preclinical diagnostic ultrasound combined with microbubbles.

Fluids and barriers of the CNS·2026
Same author

Integrated single-cell RNA sequencing analysis reveals phenotypic differences between blood endothelial cells from oral mucosa and skin.

European journal of cell biology·2026
Same author

PAD2-mediated citrullination of MBP and early myelin destabilization in multiple sclerosis.

Journal of autoimmunity·2026
Same author

Measuring blood-brain barrier dysfunction: a critical appraisal of fluid biomarkers, in vitro models, in vivo imaging, and post-mortem approaches.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Distinct CSF lipidomic profiles are associated with five proteomic subtypes in patients with Alzheimer's disease.

Molecular neurodegeneration advances·2026
Same journal

Correction.

Prion·2026
Same journal

Early diagnosis of a case of Heidenhain variant of Creutzfeld-Jakob disease by cerebrospinal fluid real-time quaking-induced conversion test.

Prion·2026
Same journal

In memoriam of Pawel P. Liberski (1954-2025).

Prion·2026
Same journal

Maternal chronic wasting disease infection restricts fetal head size in white-tailed deer (<i>Odocoileus virginianus</i>).

Prion·2026
Same journal

Plaque-type dura mater graft-associated Creutzfeldt-Jakob disease: an autopsied case report.

Prion·2026
Same journal

Efficient induction of motor neuron disease in transgenic G93A SOD1 mice by prion-like seeding.

Prion·2026
See all related articles

Related Experiment Video

Updated: May 15, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Grey matter damage in multiple sclerosis: a pathology perspective.

Roel Klaver1, Helga E De Vries, Geert J Schenk

  • 1Deptartment of Anatomy & Neurosciences, Clinical Neuroscience, VU University Medical Centre, Amsterdam, The Netherlands. r.klaver@vumc.nl

Prion
|January 18, 2013
PubMed
Summary
This summary is machine-generated.

Gray matter (GM) pathology in multiple sclerosis (MS) is extensive and detectable with new MRI techniques. This GM damage impacts motor and cognitive functions, though its exact cause in MS remains unknown.

Keywords:
clinical relevancegrey matter pathologyimagingmultiple sclerosistopology

More Related Videos

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Related Experiment Videos

Last Updated: May 15, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Area of Science:

  • Neuroimmunology
  • Neuroimaging
  • Neuropathology

Background:

  • Gray matter (GM) pathology is increasingly recognized in multiple sclerosis (MS).
  • Traditional magnetic resonance imaging (MRI) techniques struggled to visualize GM damage.
  • GM pathology is linked to motor and cognitive impairments in MS patients.

Purpose of the Study:

  • To provide an overview of gray matter damage in multiple sclerosis.
  • To focus on the topology and histopathology of GM lesions in MS.
  • To discuss the clinical relevance and potential causes of GM pathology in MS.

Main Methods:

  • Review of immunohistochemical and autopsy studies on MS brain tissue.
  • Analysis of newly developed MRI sequences for visualizing GM pathology.
  • Correlation of GM lesions and atrophy with clinical deficits.

Main Results:

  • GM pathology in MS is extensive, present from early disease stages, and progresses over time.
  • GM demyelination and microglia activation are evident in autopsy studies.
  • Unlike white matter, GM shows less immune cell influx, complement activation, and blood-brain barrier leakage.

Conclusions:

  • Newly developed MRI techniques reveal widespread GM damage in MS, correlating with clinical symptoms.
  • The precise pathogenic mechanisms driving GM damage in MS require further investigation.
  • Understanding GM pathology is crucial for MS diagnosis and treatment strategies.